Abiopharma

🔍 Chan Heng Fai Ambrose (Director)

Company: HWH International Inc. (HWH)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Sold 100,390 shares of Common Stock at $0.983 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,891,279.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: On March 30, 2026 Alset International Limited sold 100,390 shares of the Issuer's common stock at a weighted average sale price of $0.983. This transaction was executed in multiple trades at prices ranging from $0.88 to $1.22. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
• F2: The Chairman, Chief Executive Officer and majority stockholder of Alset Inc., Chan Heng Fai, may also be deemed to possess beneficial ownership of shares of the Issuer owned by Alset Inc. Alset Inc. beneficially owns 4,964,344 shares of the Issuer's common stock, including 2,537,590 shares owned directly, 1,891,279 shares owned indirectly through its majority owned subsidiary Alset International Limited, and 535,475 shares owned indirectly through another majority owned subsidiary of Alset Inc., Alset Acquisition Sponsor, LLC. Mr. Chan owns 1,002,600 shares of the Issuer's common stock personally.